Point72 Asset Management
HARP

Point72 Asset Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Point72 Asset Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-87,070
Closed -$1.66M – 1819
2022
Q2 		$1.66M Sell
87,070
-29,762
-25% -$771K 0.01% 975
2022
Q1 		$5.81M Buy
116,832
+51,832
+80% +$2.69M 0.02% 663
2021
Q4 		$4.91M Buy
+65,000
New +$4.44M 0.02% 677
2021
Q1 		– Sell
-10,000
Closed -$1.66M – 1238
2020
Q4 		$1.66M Sell
10,000
-41,639
-81% -$6.43M 0.01% 753
2020
Q3 		$8.77M Buy
+51,639
New +$7.45M 0.04% 438

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $135M AUM 0.15% 1-Year Est. Return

Point72 Asset Management's HARP Position: Q3 2022 in Review

Point72 Asset Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2022, closing a stake of 87,070 shares — an estimated $1.66M sold.

Point72 Asset Management first reported a position in HARP in Q3 2020 and held it in 5 quarters. The position peaked at $8.77M in Q3 2020. 52 funds tracked by Wall St. Rank hold HARP as of Q3 2022.

  • Point72 Asset Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Point72 Asset Management sold 87,070 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.66M.
  • Point72 Asset Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Point72 Asset Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $8.77M in Q3 2020.
  • 52 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Point72 Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.